SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature

Myasthenia gravis (MG) is an antibody-mediated immune disorder of the neuromuscular junction. SARS-CoV-2 is now recognised as a trigger factor for autoimmune diseases and to cause immune-mediated dysregulation, likely due to molecular mimicry induced by viral antigens. SARS-CoV-2 vaccination, simila...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramdas, Sithara, Hum, Ryan Malcolm, Price, Abigail, Paul, Anna, Bland, Jeremy, Burke, Georgina, Farrugia, Maria, Palace, Jacqueline, Storrie, Alice, Ho, Pauline, Standing, Emma, Lilleker, James B., Jungbluth, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443923/
https://www.ncbi.nlm.nih.gov/pubmed/36130855
http://dx.doi.org/10.1016/j.nmd.2022.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443923/
https://www.ncbi.nlm.nih.gov/pubmed/36130855
http://dx.doi.org/10.1016/j.nmd.2022.09.001

Ejemplares similares